Does RIVAROXABAN Cause Incorrect product administration duration? 47 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 47 reports of Incorrect product administration duration have been filed in association with RIVAROXABAN (Rivaroxaban). This represents 0.0% of all adverse event reports for RIVAROXABAN.
47
Reports of Incorrect product administration duration with RIVAROXABAN
0.0%
of all RIVAROXABAN reports
3
Deaths
23
Hospitalizations
How Dangerous Is Incorrect product administration duration From RIVAROXABAN?
Of the 47 reports, 3 (6.4%) resulted in death, 23 (48.9%) required hospitalization, and 3 (6.4%) were considered life-threatening.
Is Incorrect product administration duration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIVAROXABAN. However, 47 reports have been filed with the FAERS database.
What Other Side Effects Does RIVAROXABAN Cause?
Gastrointestinal haemorrhage (20,041)
Haemorrhage (6,571)
Epistaxis (5,629)
Rectal haemorrhage (4,501)
Off label use (4,463)
Haematuria (4,387)
Upper gastrointestinal haemorrhage (4,247)
Cerebrovascular accident (4,111)
Anaemia (3,907)
Acute kidney injury (3,735)
What Other Drugs Cause Incorrect product administration duration?
ETONOGESTREL (3,974)
POLYETHYLENE GLYCOL 3350 (2,129)
NIRMATRELVIR\RITONAVIR (744)
DOCOSANOL (634)
LANSOPRAZOLE (564)
LOPERAMIDE (543)
NAPROXEN (499)
INSULIN LISPRO (479)
DICLOFENAC (362)
OMEPRAZOLE (302)
Which RIVAROXABAN Alternatives Have Lower Incorrect product administration duration Risk?
RIVAROXABAN vs RIVASTIGMINE
RIVAROXABAN vs RIVOTRIL
RIVAROXABAN vs RIZATRIPTAN
RIVAROXABAN vs ROACTEMRA
RIVAROXABAN vs ROCURONIUM